Remyelination by transplanted olfactory ensheathing cells

Area of Science:

• Neuroscience
• Cell Biology
• Regenerative Medicine

Background:

• Olfactory ensheathing cells (OECs) normally associate with small-diameter olfactory axons but do not myelinate them.
• OECs possess an intrinsic plasticity allowing them to adopt a myelinating phenotype when encountering larger axons in different environments.

Purpose of the Study:

• To investigate the myelinating potential of transplanted OECs in models of central nervous system (CNS) demyelination.
• To explore factors that augment OEC myelinating capacity, such as the presence of meningeal cells.
• To compare the therapeutic potential of OECs versus Schwann cells for CNS repair.

Main Methods:

• Transplantation of OECs into experimental models of primary demyelination.
• Analysis of OEC morphology, ultrastructure, biochemistry, and transcriptional regulation post-transplantation.
• Comparative studies of OECs and Schwann cells in astrocyte-containing CNS lesions.

Main Results:

• Transplanted OECs effectively myelinate larger-diameter axons, becoming indistinguishable from myelinating Schwann cells.
• The myelinating capacity of transplanted OECs can be significantly enhanced by co-transplantation with meningeal cells.
• OECs demonstrate comparable or superior performance to Schwann cells in promoting repair in demyelinated CNS lesions.

Conclusions:

• OECs possess significant intrinsic myelinating potential, which can be harnessed for therapeutic purposes in demyelinating diseases.
• Meningeal cells act as crucial supportive elements, augmenting OEC-mediated myelination.
• Transplanted OECs represent a promising cell-based therapy for conditions like multiple sclerosis, offering a viable alternative to Schwann cells.